News stories about MetLife (NYSE:MET) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. MetLife earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned news headlines about the financial services provider an impact score of 46.3867351954399 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Here are some of the headlines that may have impacted Accern Sentiment Analysis’s analysis:

Shares of MetLife (NYSE MET) traded up $0.15 during trading on Friday, hitting $53.76. The stock had a trading volume of 3,690,000 shares, compared to its average volume of 3,950,000. The firm has a market cap of $56,570.00, a price-to-earnings ratio of 10.34, a price-to-earnings-growth ratio of 1.35 and a beta of 1.49. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.31. MetLife has a fifty-two week low of $44.43 and a fifty-two week high of $55.91.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, November 1st. The financial services provider reported $1.09 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.19. MetLife had a positive return on equity of 8.81% and a negative net margin of 0.75%. The business had revenue of $16.10 billion during the quarter, compared to analyst estimates of $15.47 billion. During the same period in the previous year, the company earned $1.28 EPS. The firm’s revenue was up 1.7% on a year-over-year basis. equities research analysts predict that MetLife will post 4.43 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 13th. Shareholders of record on Monday, November 6th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.98%. The ex-dividend date of this dividend is Friday, November 3rd. MetLife’s dividend payout ratio is currently 347.83%.

Several equities analysts recently issued reports on the company. Royal Bank Of Canada restated an “outperform” rating and set a $60.00 price objective (up from $56.00) on shares of MetLife in a research note on Friday, November 3rd. Morgan Stanley lifted their target price on MetLife from $55.00 to $56.00 and gave the stock an “equal weight” rating in a report on Friday, November 3rd. Argus lifted their price target on MetLife from $55.00 to $60.00 and gave the stock a “buy” rating in a research note on Monday, November 6th. Zacks Investment Research raised MetLife from a “strong sell” rating to a “hold” rating in a research note on Monday, October 9th. Finally, ValuEngine cut MetLife from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, October 10th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. MetLife presently has an average rating of “Buy” and an average price target of $58.40.

In other news, insider Christopher G. Townsend sold 82,731 shares of the business’s stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the sale, the insider now directly owns 49,660 shares in the company, valued at $2,711,436. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Christopher G. Townsend sold 55,712 shares of the business’s stock in a transaction that occurred on Monday, November 6th. The shares were sold at an average price of $54.29, for a total value of $3,024,604.48. Following the sale, the insider now owns 25,181 shares in the company, valued at $1,367,076.49. The disclosure for this sale can be found here. Insiders own 0.32% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Insider Buying and Selling by Quarter for MetLife (NYSE:MET)

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.